SAI-CHING J YEUNG to Administration, Oral
This is a "connection" page, showing publications SAI-CHING J YEUNG has written about Administration, Oral.
Connection Strength
0.079
-
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer. Cancer Chemother Pharmacol. 2013 Jan; 71(1):63-72.
Score: 0.079